136 related articles for article (PubMed ID: 19900614)
1. BAC to degeneration bacterial artificial chromosome (BAC)-mediated transgenesis for modeling basal ganglia neurodegenerative disorders.
Lu XH
Int Rev Neurobiol; 2009; 89():37-56. PubMed ID: 19900614
[TBL] [Abstract][Full Text] [Related]
2. BAC to immunology--bacterial artificial chromosome-mediated transgenesis for targeting of immune cells.
Sparwasser T; Eberl G
Immunology; 2007 Jul; 121(3):308-13. PubMed ID: 17437533
[TBL] [Abstract][Full Text] [Related]
3. Molecular mediators, environmental modulators and experience-dependent synaptic dysfunction in Huntington's disease.
Hannan AJ
Acta Biochim Pol; 2004; 51(2):415-30. PubMed ID: 15218539
[TBL] [Abstract][Full Text] [Related]
4. α-Synuclein BAC transgenic mice as a model for Parkinson's disease manifested decreased anxiety-like behavior and hyperlocomotion.
Yamakado H; Moriwaki Y; Yamasaki N; Miyakawa T; Kurisu J; Uemura K; Inoue H; Takahashi M; Takahashi R
Neurosci Res; 2012 Jun; 73(2):173-7. PubMed ID: 22475625
[TBL] [Abstract][Full Text] [Related]
5. Targeting iCre expression to murine progesterone receptor cell-lineages using bacterial artificial chromosome transgenesis.
Mukherjee A; Soyal SM; Wheeler DA; Fernandez-Valdivia R; Nguyen J; DeMayo FJ; Lydon JP
Genesis; 2006 Dec; 44(12):601-10. PubMed ID: 17149722
[TBL] [Abstract][Full Text] [Related]
6. [Establishment of BAC mediated transgenic mice containing 97 kb beta-globin gene cluster].
Shen W; Huang Y; Tang Y; Liu DP; Liu G; Wu M; Liang CC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):117-21. PubMed ID: 12905702
[TBL] [Abstract][Full Text] [Related]
7. Global changes to the ubiquitin system in Huntington's disease.
Bennett EJ; Shaler TA; Woodman B; Ryu KY; Zaitseva TS; Becker CH; Bates GP; Schulman H; Kopito RR
Nature; 2007 Aug; 448(7154):704-8. PubMed ID: 17687326
[TBL] [Abstract][Full Text] [Related]
8. Genes and the environment in neurodegeneration.
Coppedè F; Mancuso M; Siciliano G; Migliore L; Murri L
Biosci Rep; 2006 Oct; 26(5):341-67. PubMed ID: 17029001
[TBL] [Abstract][Full Text] [Related]
9. Modeling brain reserve: experience-dependent neuronal plasticity in healthy and Huntington's disease transgenic mice.
Nithianantharajah J; Barkus C; Vijiaratnam N; Clement O; Hannan AJ
Am J Geriatr Psychiatry; 2009 Mar; 17(3):196-209. PubMed ID: 19454847
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetics, basal ganglia disorders, and the clinical neurologist.
Eldridge R
Neurol Clin; 1984 Aug; 2(3):581-603. PubMed ID: 6241956
[TBL] [Abstract][Full Text] [Related]
11. Nature, nurture and neurology: gene-environment interactions in neurodegenerative disease. FEBS Anniversary Prize Lecture delivered on 27 June 2004 at the 29th FEBS Congress in Warsaw.
Spires TL; Hannan AJ
FEBS J; 2005 May; 272(10):2347-61. PubMed ID: 15885086
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of neurodegenerative disorders: how good are they?
Rachakonda V; Pan TH; LE WD
Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
[TBL] [Abstract][Full Text] [Related]
13. Proper developmental control of human globin genes reproduced by transgenic mice containing a 160-kb BAC carrying the human beta-globin locus.
Huang Y; Liu DP; Wu L; Li TC; Wu M; Feng DX; Liang CC
Blood Cells Mol Dis; 2000 Dec; 26(6):598-610. PubMed ID: 11358351
[TBL] [Abstract][Full Text] [Related]
14. Error processing in normal aging and in basal ganglia disorders.
Beste C; Willemssen R; Saft C; Falkenstein M
Neuroscience; 2009 Mar; 159(1):143-9. PubMed ID: 19166908
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in neural transplantation. Relevance to neurodegenerative disorders.
Borlongan CV; Cahill DW; Freeman TB; Sanberg PR
J Fla Med Assoc; 1994 Oct; 81(10):689-94. PubMed ID: 7798875
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria and neurodegeneration.
Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
[TBL] [Abstract][Full Text] [Related]
17. What transgenic mice tell us about neurodegenerative disease.
Gurney ME
Bioessays; 2000 Mar; 22(3):297-304. PubMed ID: 10684590
[TBL] [Abstract][Full Text] [Related]
18. DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations.
Crocker SF; Costain WJ; Robertson HA
Brain Res; 2006 May; 1088(1):176-86. PubMed ID: 16626669
[TBL] [Abstract][Full Text] [Related]
19. Gait variability and basal ganglia disorders: stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease.
Hausdorff JM; Cudkowicz ME; Firtion R; Wei JY; Goldberger AL
Mov Disord; 1998 May; 13(3):428-37. PubMed ID: 9613733
[TBL] [Abstract][Full Text] [Related]
20. [Neuropsychological evaluation can contribute to the diagnosis of movement disorders].
Dubois B; Beato R; Villalpando JM
Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S50-6. PubMed ID: 12773888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
